ACS
Archford Capital Strategies Portfolio holdings
AUM
$782M
1-Year Return
16.93%
This Quarter Return
-3.49%
1 Year Return
+16.93%
3 Year Return
+57.74%
5 Year Return
+86.93%
10 Year Return
+191.61%
AUM
$240M
AUM Growth
-$28.6M
(-11%)
Cap. Flow
-$31.5M
Cap. Flow
% of AUM
-13.13%
Top 10 Holdings %
Top 10 Hldgs %
27.36%
Holding
721
New
537
Increased
75
Reduced
4
Closed
70
Top Buys
| 1 |
AstraZeneca
AZN
|
+$1.63M |
| 2 |
IBMG
iShares iBonds Sep 2018 Term Muni Bond ETF
IBMG
|
+$418K |
| 3 |
O'Reilly Automotive
ORLY
|
+$191K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$190K |
| 5 |
APU
AmeriGas Partners, L.P.
APU
|
+$190K |
Top Sells
| 1 |
American Water Works
AWK
|
+$4.3M |
| 2 |
Boeing
BA
|
+$2.56M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.5M |
| 4 |
Blackrock
BLK
|
+$1.8M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.34M |
Sector Composition
| 1 | Consumer Staples | 11.92% |
| 2 | Industrials | 10.79% |
| 3 | Financials | 9.69% |
| 4 | Technology | 8.28% |
| 5 | Healthcare | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
West Pharmaceutical
WST
$18.2B
| $5K | ﹤0.01% |
+50
| New | +$5K |
|
402
ASML
ASML
$317B
| $4K | ﹤0.01% |
+21
| New | +$4K |
|
403
CoStar Group
CSGP
$37.3B
| $4K | ﹤0.01% |
+150
| New | +$4K |
|
404
Dell
DELL
$82B
| $4K | ﹤0.01% |
+196
| New | +$4K |
|
405
Darden Restaurants
DRI
$24.7B
| $4K | ﹤0.01% |
+42
| New | +$4K |
|
406
Exponent
EXPO
$3.59B
| $4K | ﹤0.01% |
+100
| New | +$4K |
|
407
Five Below
FIVE
$8.34B
| $4K | ﹤0.01% |
+55
| New | +$4K |
|
408
Booz Allen Hamilton
BAH
$12.5B
| $4K | ﹤0.01% |
+106
| New | +$4K |
|
409
Burlington
BURL
$18.3B
| $4K | ﹤0.01% |
+31
| New | +$4K |
|
410
BorgWarner
BWA
$9.45B
| $4K | ﹤0.01% |
+92
| New | +$4K |
|
411
CBRE Group
CBRE
$48.2B
| $4K | ﹤0.01% |
+98
| New | +$4K |
|
412
Cognex
CGNX
$7.49B
| $4K | ﹤0.01% |
+68
| New | +$4K |
|
413
Carter's
CRI
$1.05B
| $4K | ﹤0.01% |
+32
| New | +$4K |
|
414
Flex
FLEX
$20.9B
| $4K | ﹤0.01% |
+321
| New | +$4K |
|
415
Fortive
FTV
$16.2B
| $4K | ﹤0.01% |
+60
| New | +$4K |
|
416
HCA Healthcare
HCA
$97.8B
| $4K | ﹤0.01% |
+41
| New | +$4K |
|
417
Humana
HUM
$32.8B
| $4K | ﹤0.01% |
17
-3,352
| -99% | -$789K |
|
418
ICU Medical
ICUI
$3.22B
| $4K | ﹤0.01% |
+20
| New | +$4K |
|
|
INN
419
Summit Hotel Properties
INN
$608M
| $4K | ﹤0.01% |
+246
| New | +$4K |
|
420
Ingersoll Rand
IR
$31.9B
| $4K | ﹤0.01% |
+111
| New | +$4K |
|
421
Labcorp
LH
$23B
| $4K | ﹤0.01% |
+31
| New | +$4K |
|
422
Nordson
NDSN
$12.7B
| $4K | ﹤0.01% |
+25
| New | +$4K |
|
423
OGE Energy
OGE
$8.82B
| $4K | ﹤0.01% |
+100
| New | +$4K |
|
424
Pricesmart
PSMT
$3.44B
| $4K | ﹤0.01% |
+43
| New | +$4K |
|
425
Stifel
SF
$11.5B
| $4K | ﹤0.01% |
+98
| New | +$4K |
|